Skip to content

Building a Culture of Innovation

   by Joseph E. Fournier, President & Vice Chairman, Invenias Partners Forbes annually publishes its roster of the World’s Most Innovative Companies. The 2018 list is more than a roll call of Silicon Valley tech companies, with Alphabet…

Read more

(NEW) Guidepoint Qsight Model: Medtronic

   by Robert Conklin, Vice President of Sales, Guidepoint Data With the addition of Medtronic (“MDT”) to our Guidepoint Qsight data-sets, we now have 16 company models available across the MedTech space. This timely data, gathered from over…

Read more

The “Impact” in Impact Investing

   by Nick Bayard, President & CEO, Bayard Consulting At a quarter of a trillion dollars, the market for impact investing is enormous and rapidly growing. Investors who expect a double or triple bottom line are expecting those…

Read more

The “Impact” in Impact Investing

   by Nick Bayard, President & CEO, Bayard Consulting At a quarter of a trillion dollars, the market for impact investing is enormous and rapidly growing. Investors who expect a double or triple bottom line are expecting those…

Read more

The “Impact” in Impact Investing

   by Nick Bayard, President & CEO, Bayard Consulting At a quarter of a trillion dollars, the market for impact investing is enormous and rapidly growing. Investors who expect a double or triple bottom line are expecting those…

Read more

Evaluating Anti-Cancer Prescriptions

     CLIENT SITUATION A healthcare team working on behalf of a pharmaceutical company wanted to better understand how anti-cancer pharmaceuticals are evaluated for inclusion on payer prescription lists. They were conducting strategy research and needed a large…

Read more

Maintaining Integrity in the Corporate World

   by Mani Padmanabhan, CFO and Co Founder at Price Eagle Online We are living in a globalized, hyper-connected world with faster and easier information access. Laws are increasingly becoming stronger and trans-jurisdictional every day. The enforcement actions…

Read more

(NEW) Guidepoint Qsight Models: MMSI, CNMD, SIBN

   by Kenny Dolgin, Healthcare Analyst, Guidepoint Data Guidepoint Data is excited to announce that we have expanded Guidepoint Qsight’s data product offering to include models for three new companies: Merit Medical (“MMSI”), CONMED (“CNMD”), and SI-BONE (“SIBN”)…

Read more

Gaining Insight Into Innovative Medical Product Development

     CLIENT SITUATION A senior scientist at a large medical device company wanted to connect with Research & Development (R&D) engineers, scientists, clinicians, and chemists who focus on drug delivery or drug-eluting systems for implantable medical devices…

Read more
Back To Top